PortfoliosLab logo

Novo Nordisk A/S (NVO)

Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US6701002056
CUSIP
670100205

NVOPrice Chart


Chart placeholderClick Calculate to get results

NVOPerformance

The chart shows the growth of $10,000 invested in Novo Nordisk A/S on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $89,557 for a total return of roughly 795.57%. All prices are adjusted for splits and dividends.


NVO (Novo Nordisk A/S)
Benchmark (S&P 500)

NVOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD-14.00%-2.17%
1M-14.63%0.62%
6M10.54%6.95%
1Y38.54%22.39%
5Y24.56%15.44%
10Y17.34%13.73%

NVOMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

NVOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Novo Nordisk A/S Sharpe ratio is 1.91. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


NVO (Novo Nordisk A/S)
Benchmark (S&P 500)

NVODividends

Novo Nordisk A/S granted a 1.56% dividend yield in the last twelve months, as of Jan 15, 2022. The annual payout for that period amounted to $1.50 per share.


PeriodTTM202120202019201820172016201520142013201220112010
Dividend$1.50$1.50$1.30$1.23$0.91$0.82$1.03$0.53$0.61$0.45$0.37$0.27$0.20

Dividend yield

1.56%1.34%1.90%2.21%2.10%1.65%3.19%1.04%1.64%1.42%1.32%1.40%1.05%

NVODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


NVO (Novo Nordisk A/S)
Benchmark (S&P 500)

NVOWorst Drawdowns

The table below shows the maximum drawdowns of the Novo Nordisk A/S. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Novo Nordisk A/S is 46.54%, recorded on Nov 23, 2016. It took 289 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-46.54%Aug 4, 2015332Nov 23, 2016289Jan 22, 2018621
-28.04%Apr 25, 2011117Oct 7, 201183Feb 7, 2012200
-27.2%Jan 29, 2018179Oct 11, 2018266Nov 1, 2019445
-23.65%Mar 5, 202012Mar 20, 202020Apr 20, 202032
-21.45%Feb 7, 201395Jun 24, 2013139Jan 10, 2014234
-17.73%Dec 17, 202120Jan 14, 2022
-14.66%Oct 23, 20129Nov 6, 201244Jan 10, 201353
-14.54%Sep 19, 201475Jan 6, 201549Mar 18, 2015124
-13.91%Apr 23, 201230Jun 4, 201238Jul 27, 201268
-13.22%Oct 13, 202014Oct 30, 202034Dec 18, 202048

NVOVolatility Chart

Current Novo Nordisk A/S volatility is 22.72%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


NVO (Novo Nordisk A/S)
Benchmark (S&P 500)

Portfolios with Novo Nordisk A/S


Loading data...

More Tools for Novo Nordisk A/S